![](/img/cover-not-exists.png)
Cost-effective models for flutamide for prostate carcinoma patients: Are they helpful to policy makers?
Charles L. Bennett, David Matchar, Doug McCrory, David G. McLeod, E. David Crawford, Bruce E. HillnerVolume:
77
Year:
1996
Language:
english
Pages:
8
DOI:
10.1002/(sici)1097-0142(19960501)77:93.0.co;2-z
File:
PDF, 761 KB
english, 1996